Now live: Pro — the full 13F research suite for serious investorsSee pricing →
22NW, LP

Q3 2024 · 13F-HR

22NW, LPholdings as filed

Filed 2024-11-14 · accession 0001214659-24-019159

$119.3M
Reported value
13
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
350060109FSTRFOSTER L B CO$26.8M22.5%1,313,121CommonSOLE
514766104LFCRLIFECORE BIOMEDICAL INC$23.7M19.8%1,755,161CommonSOLE
859241101STRLSTERLING INFRASTRUCTURE INC$14.5M12.1%99,783CommonSOLE
230215105CULPCULP INC$10.4M8.76%1,594,390CommonSOLE
034569103ANEBANEBULO PHARMACEUTICALS INC$10.4M8.68%5,366,290CommonSOLE
068463108BBSIBARRETT BUSINESS SVCS INC$9.9M8.33%264,904CommonSOLE
71742W103PFXPHENIXFIN CORP$5.6M4.69%117,885CommonSOLE
23331S100DHXDHI GROUP INC$4.8M4.02%2,603,643CommonSOLE
307675108FB1FARMER BROS CO$3.9M3.25%1,955,526CommonSOLE
516544103LNTHLANTHEUS HLDGS INC$3.8M3.18%34,562CommonSOLE
563571405MTWMANITOWOC CO INC$3.4M2.87%356,115CommonSOLE
86272A305SSKNSTRATA SKIN SCIENCES INC CMN$1.5M1.24%536,995CommonSOLE
744375205PMDUSDPSYCHEMEDICS CORP$637,6390.53%276,034CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.